nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—CES1—Capecitabine—breast cancer	0.196	0.334	CbGbCtD
Oseltamivir—CES1—Tamoxifen—breast cancer	0.158	0.269	CbGbCtD
Oseltamivir—CES1—Irinotecan—breast cancer	0.121	0.206	CbGbCtD
Oseltamivir—ABCC4—Fluorouracil—breast cancer	0.059	0.101	CbGbCtD
Oseltamivir—ABCC4—Methotrexate—breast cancer	0.0325	0.0554	CbGbCtD
Oseltamivir—SLC22A8—Methotrexate—breast cancer	0.0203	0.0346	CbGbCtD
Oseltamivir—NEU1—nipple—breast cancer	0.00619	0.14	CbGeAlD
Oseltamivir—NEU1—endometrium—breast cancer	0.00374	0.0846	CbGeAlD
Oseltamivir—NEU1—pituitary gland—breast cancer	0.00338	0.0766	CbGeAlD
Oseltamivir—NEU1—adipose tissue—breast cancer	0.00337	0.0763	CbGeAlD
Oseltamivir—NEU1—adrenal gland—breast cancer	0.00302	0.0684	CbGeAlD
Oseltamivir—NEU1—bone marrow—breast cancer	0.00292	0.0662	CbGeAlD
Oseltamivir—NEU1—female gonad—breast cancer	0.00282	0.0638	CbGeAlD
Oseltamivir—NEU1—lymph node—breast cancer	0.00181	0.041	CbGeAlD
Oseltamivir—SLC15A1—epithelium—breast cancer	0.00156	0.0352	CbGeAlD
Oseltamivir—SLC15A1—endometrium—breast cancer	0.00139	0.0316	CbGeAlD
Oseltamivir—CES1—adipose tissue—breast cancer	0.00135	0.0307	CbGeAlD
Oseltamivir—CES1—female reproductive system—breast cancer	0.00124	0.0282	CbGeAlD
Oseltamivir—CES1—adrenal gland—breast cancer	0.00121	0.0275	CbGeAlD
Oseltamivir—CES1—female gonad—breast cancer	0.00113	0.0257	CbGeAlD
Oseltamivir—CES1—endocrine gland—breast cancer	0.00105	0.0239	CbGeAlD
Oseltamivir—SLC15A1—endocrine gland—breast cancer	0.000978	0.0221	CbGeAlD
Oseltamivir—ABCC4—uterus—breast cancer	0.000932	0.0211	CbGeAlD
Oseltamivir—ABCC4—adipose tissue—breast cancer	0.000911	0.0206	CbGeAlD
Oseltamivir—ABCC4—female reproductive system—breast cancer	0.000838	0.019	CbGeAlD
Oseltamivir—ABCC4—adrenal gland—breast cancer	0.000818	0.0185	CbGeAlD
Oseltamivir—ABCC4—bone marrow—breast cancer	0.000791	0.0179	CbGeAlD
Oseltamivir—ABCC4—female gonad—breast cancer	0.000762	0.0173	CbGeAlD
Oseltamivir—CES1—lymph node—breast cancer	0.000728	0.0165	CbGeAlD
Oseltamivir—ABCC4—endocrine gland—breast cancer	0.000709	0.0161	CbGeAlD
Oseltamivir—ABCC4—lymph node—breast cancer	0.00049	0.0111	CbGeAlD
Oseltamivir—NEU2—Metabolism—GPX4—breast cancer	9.24e-05	0.000749	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—SULT1A1—breast cancer	9.24e-05	0.000749	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—NRG1—breast cancer	9.17e-05	0.000744	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTT1—breast cancer	9.13e-05	0.00074	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ACHE—breast cancer	9.13e-05	0.00074	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—IDH1—breast cancer	9.02e-05	0.000731	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTA1—breast cancer	9.02e-05	0.000731	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	9.01e-05	0.000731	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ATP7B—breast cancer	8.99e-05	0.000729	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—FGFR2—breast cancer	8.98e-05	0.000728	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NAT2—breast cancer	8.92e-05	0.000723	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—STIM1—breast cancer	8.86e-05	0.000718	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC39A6—breast cancer	8.74e-05	0.000709	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP17A1—breast cancer	8.64e-05	0.0007	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTGS1—breast cancer	8.55e-05	0.000693	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ENO1—breast cancer	8.55e-05	0.000693	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	8.52e-05	0.000691	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—ALB—breast cancer	8.41e-05	0.000682	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP2D6—breast cancer	8.39e-05	0.00068	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC39A6—breast cancer	8.38e-05	0.00068	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ABCC1—breast cancer	8.36e-05	0.000678	CbGpPWpGaD
Oseltamivir—Asthenia—Irinotecan—breast cancer	8.32e-05	0.000339	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	8.31e-05	0.000338	CcSEcCtD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—breast cancer	8.3e-05	0.000673	CbGpPWpGaD
Oseltamivir—Cough—Capecitabine—breast cancer	8.3e-05	0.000338	CcSEcCtD
Oseltamivir—Jaundice—Epirubicin—breast cancer	8.27e-05	0.000336	CcSEcCtD
Oseltamivir—Conjunctivitis—Epirubicin—breast cancer	8.24e-05	0.000335	CcSEcCtD
Oseltamivir—NEU1—Metabolism—NCOA2—breast cancer	8.23e-05	0.000667	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Fluorouracil—breast cancer	8.18e-05	0.000333	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Doxorubicin—breast cancer	8.18e-05	0.000333	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Paclitaxel—breast cancer	8.17e-05	0.000332	CcSEcCtD
Oseltamivir—Fatigue—Paclitaxel—breast cancer	8.16e-05	0.000332	CcSEcCtD
Oseltamivir—Hepatitis—Methotrexate—breast cancer	8.13e-05	0.000331	CcSEcCtD
Oseltamivir—Asthenia—Gemcitabine—breast cancer	8.11e-05	0.00033	CcSEcCtD
Oseltamivir—Myalgia—Capecitabine—breast cancer	8.1e-05	0.00033	CcSEcCtD
Oseltamivir—Arthralgia—Capecitabine—breast cancer	8.1e-05	0.00033	CcSEcCtD
Oseltamivir—Pain—Paclitaxel—breast cancer	8.09e-05	0.000329	CcSEcCtD
Oseltamivir—Confusional state—Docetaxel—breast cancer	8.09e-05	0.000329	CcSEcCtD
Oseltamivir—Anxiety—Capecitabine—breast cancer	8.07e-05	0.000328	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	8.06e-05	0.000654	CbGpPWpGaD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	8.04e-05	0.000327	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Epirubicin—breast cancer	8.02e-05	0.000326	CcSEcCtD
Oseltamivir—Anaphylactic shock—Docetaxel—breast cancer	8.02e-05	0.000326	CcSEcCtD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—breast cancer	8.02e-05	0.00065	CbGpPWpGaD
Oseltamivir—Epistaxis—Epirubicin—breast cancer	8e-05	0.000325	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ATP7B—breast cancer	8e-05	0.000648	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—FASN—breast cancer	7.98e-05	0.000647	CbGpPWpGaD
Oseltamivir—Nausea—Thiotepa—breast cancer	7.98e-05	0.000325	CcSEcCtD
Oseltamivir—Infection—Docetaxel—breast cancer	7.97e-05	0.000324	CcSEcCtD
Oseltamivir—Sinusitis—Epirubicin—breast cancer	7.96e-05	0.000324	CcSEcCtD
Oseltamivir—NEU1—Metabolism—BCHE—breast cancer	7.95e-05	0.000645	CbGpPWpGaD
Oseltamivir—Diarrhoea—Irinotecan—breast cancer	7.94e-05	0.000323	CcSEcCtD
Oseltamivir—Diarrhoea—Mitoxantrone—breast cancer	7.94e-05	0.000323	CcSEcCtD
Oseltamivir—Pneumonia—Doxorubicin—breast cancer	7.89e-05	0.000321	CcSEcCtD
Oseltamivir—Nervous system disorder—Docetaxel—breast cancer	7.86e-05	0.00032	CcSEcCtD
Oseltamivir—NEU1—Metabolism—SLC5A5—breast cancer	7.85e-05	0.000637	CbGpPWpGaD
Oseltamivir—Thrombocytopenia—Docetaxel—breast cancer	7.85e-05	0.000319	CcSEcCtD
Oseltamivir—Infestation NOS—Doxorubicin—breast cancer	7.85e-05	0.000319	CcSEcCtD
Oseltamivir—Infestation—Doxorubicin—breast cancer	7.85e-05	0.000319	CcSEcCtD
Oseltamivir—Visual impairment—Methotrexate—breast cancer	7.84e-05	0.000319	CcSEcCtD
Oseltamivir—Confusional state—Capecitabine—breast cancer	7.83e-05	0.000319	CcSEcCtD
Oseltamivir—NEU2—Metabolism—MED12—breast cancer	7.82e-05	0.000634	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—DPYD—breast cancer	7.82e-05	0.000634	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PLG—breast cancer	7.8e-05	0.000633	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Paclitaxel—breast cancer	7.8e-05	0.000317	CcSEcCtD
Oseltamivir—Skin disorder—Docetaxel—breast cancer	7.79e-05	0.000317	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Doxorubicin—breast cancer	7.78e-05	0.000317	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—F3—breast cancer	7.74e-05	0.000628	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Paclitaxel—breast cancer	7.74e-05	0.000315	CcSEcCtD
Oseltamivir—Diarrhoea—Gemcitabine—breast cancer	7.73e-05	0.000315	CcSEcCtD
Oseltamivir—Infection—Capecitabine—breast cancer	7.71e-05	0.000314	CcSEcCtD
Oseltamivir—NEU2—Metabolism—ALDOA—breast cancer	7.7e-05	0.000624	CbGpPWpGaD
Oseltamivir—Erythema multiforme—Methotrexate—breast cancer	7.69e-05	0.000313	CcSEcCtD
Oseltamivir—Dizziness—Irinotecan—breast cancer	7.67e-05	0.000312	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—IGF1—breast cancer	7.67e-05	0.000622	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ATP7B—breast cancer	7.67e-05	0.000622	CbGpPWpGaD
Oseltamivir—Jaundice—Doxorubicin—breast cancer	7.65e-05	0.000311	CcSEcCtD
Oseltamivir—Conjunctivitis—Doxorubicin—breast cancer	7.63e-05	0.00031	CcSEcCtD
Oseltamivir—Nervous system disorder—Capecitabine—breast cancer	7.61e-05	0.00031	CcSEcCtD
Oseltamivir—Hepatitis—Epirubicin—breast cancer	7.61e-05	0.00031	CcSEcCtD
Oseltamivir—Eye disorder—Methotrexate—breast cancer	7.6e-05	0.000309	CcSEcCtD
Oseltamivir—Diarrhoea—Fluorouracil—breast cancer	7.6e-05	0.000309	CcSEcCtD
Oseltamivir—Thrombocytopenia—Capecitabine—breast cancer	7.6e-05	0.000309	CcSEcCtD
Oseltamivir—NEU1—Metabolism—SLC2A1—breast cancer	7.58e-05	0.000615	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—NQO1—breast cancer	7.58e-05	0.000615	CbGpPWpGaD
Oseltamivir—Cardiac disorder—Methotrexate—breast cancer	7.55e-05	0.000307	CcSEcCtD
Oseltamivir—Skin disorder—Capecitabine—breast cancer	7.54e-05	0.000307	CcSEcCtD
Oseltamivir—Urticaria—Paclitaxel—breast cancer	7.52e-05	0.000306	CcSEcCtD
Oseltamivir—Body temperature increased—Paclitaxel—breast cancer	7.48e-05	0.000304	CcSEcCtD
Oseltamivir—Abdominal pain—Paclitaxel—breast cancer	7.48e-05	0.000304	CcSEcCtD
Oseltamivir—NEU2—Metabolism—NCOA3—breast cancer	7.47e-05	0.000606	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ABCC1—breast cancer	7.44e-05	0.000603	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.43e-05	0.000602	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—SLC2A2—breast cancer	7.42e-05	0.000602	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—MMP2—breast cancer	7.42e-05	0.000602	CbGpPWpGaD
Oseltamivir—Hepatobiliary disease—Doxorubicin—breast cancer	7.42e-05	0.000302	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PDGFA—breast cancer	7.41e-05	0.0006	CbGpPWpGaD
Oseltamivir—Epistaxis—Doxorubicin—breast cancer	7.4e-05	0.000301	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYP3A4—breast cancer	7.4e-05	0.0006	CbGpPWpGaD
Oseltamivir—Vomiting—Irinotecan—breast cancer	7.38e-05	0.0003	CcSEcCtD
Oseltamivir—Vomiting—Mitoxantrone—breast cancer	7.38e-05	0.0003	CcSEcCtD
Oseltamivir—Sinusitis—Doxorubicin—breast cancer	7.36e-05	0.0003	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.36e-05	0.000597	CbGpPWpGaD
Oseltamivir—Immune system disorder—Methotrexate—breast cancer	7.35e-05	0.000299	CcSEcCtD
Oseltamivir—Dizziness—Fluorouracil—breast cancer	7.35e-05	0.000299	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	7.35e-05	0.000596	CbGpPWpGaD
Oseltamivir—Visual impairment—Epirubicin—breast cancer	7.34e-05	0.000299	CcSEcCtD
Oseltamivir—Mediastinal disorder—Methotrexate—breast cancer	7.33e-05	0.000298	CcSEcCtD
Oseltamivir—Rash—Irinotecan—breast cancer	7.31e-05	0.000298	CcSEcCtD
Oseltamivir—Rash—Mitoxantrone—breast cancer	7.31e-05	0.000298	CcSEcCtD
Oseltamivir—Dermatitis—Mitoxantrone—breast cancer	7.31e-05	0.000297	CcSEcCtD
Oseltamivir—Dermatitis—Irinotecan—breast cancer	7.31e-05	0.000297	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Docetaxel—breast cancer	7.31e-05	0.000297	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYP1B1—breast cancer	7.27e-05	0.00059	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—MTR—breast cancer	7.27e-05	0.00059	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ABCG2—breast cancer	7.27e-05	0.00059	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CPT1A—breast cancer	7.27e-05	0.00059	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—MMP1—breast cancer	7.27e-05	0.000589	CbGpPWpGaD
Oseltamivir—Headache—Mitoxantrone—breast cancer	7.27e-05	0.000296	CcSEcCtD
Oseltamivir—Headache—Irinotecan—breast cancer	7.27e-05	0.000296	CcSEcCtD
Oseltamivir—Insomnia—Docetaxel—breast cancer	7.25e-05	0.000295	CcSEcCtD
Oseltamivir—Erythema multiforme—Epirubicin—breast cancer	7.2e-05	0.000293	CcSEcCtD
Oseltamivir—Vomiting—Gemcitabine—breast cancer	7.18e-05	0.000292	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—ITPR1—breast cancer	7.18e-05	0.000582	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—HSP90AA1—breast cancer	7.13e-05	0.000578	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—HPGDS—breast cancer	7.13e-05	0.000578	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ABCC1—breast cancer	7.13e-05	0.000578	CbGpPWpGaD
Oseltamivir—Mental disorder—Methotrexate—breast cancer	7.13e-05	0.00029	CcSEcCtD
Oseltamivir—Rash—Gemcitabine—breast cancer	7.12e-05	0.00029	CcSEcCtD
Oseltamivir—Dermatitis—Gemcitabine—breast cancer	7.12e-05	0.00029	CcSEcCtD
Oseltamivir—Eye disorder—Epirubicin—breast cancer	7.11e-05	0.00029	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—TUBB3—breast cancer	7.11e-05	0.000576	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—HBA1—breast cancer	7.09e-05	0.000574	CbGpPWpGaD
Oseltamivir—Headache—Gemcitabine—breast cancer	7.08e-05	0.000288	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Capecitabine—breast cancer	7.07e-05	0.000288	CcSEcCtD
Oseltamivir—Cardiac disorder—Epirubicin—breast cancer	7.07e-05	0.000288	CcSEcCtD
Oseltamivir—Vomiting—Fluorouracil—breast cancer	7.06e-05	0.000287	CcSEcCtD
Oseltamivir—Dyspepsia—Docetaxel—breast cancer	7.06e-05	0.000287	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—TGFB1—breast cancer	7.06e-05	0.000572	CbGpPWpGaD
Oseltamivir—Hepatitis—Doxorubicin—breast cancer	7.04e-05	0.000287	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—LEP—breast cancer	7.03e-05	0.00057	CbGpPWpGaD
Oseltamivir—Insomnia—Capecitabine—breast cancer	7.02e-05	0.000286	CcSEcCtD
Oseltamivir—Rash—Fluorouracil—breast cancer	7e-05	0.000285	CcSEcCtD
Oseltamivir—Dermatitis—Fluorouracil—breast cancer	7e-05	0.000285	CcSEcCtD
Oseltamivir—Hypersensitivity—Paclitaxel—breast cancer	6.97e-05	0.000284	CcSEcCtD
Oseltamivir—Headache—Fluorouracil—breast cancer	6.96e-05	0.000283	CcSEcCtD
Oseltamivir—NEU1—Metabolism—NCOA1—breast cancer	6.94e-05	0.000562	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Docetaxel—breast cancer	6.92e-05	0.000282	CcSEcCtD
Oseltamivir—NEU2—Metabolism—ACHE—breast cancer	6.92e-05	0.000561	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTT1—breast cancer	6.92e-05	0.000561	CbGpPWpGaD
Oseltamivir—Fatigue—Docetaxel—breast cancer	6.91e-05	0.000281	CcSEcCtD
Oseltamivir—Nausea—Irinotecan—breast cancer	6.89e-05	0.00028	CcSEcCtD
Oseltamivir—Nausea—Mitoxantrone—breast cancer	6.89e-05	0.00028	CcSEcCtD
Oseltamivir—Immune system disorder—Epirubicin—breast cancer	6.88e-05	0.00028	CcSEcCtD
Oseltamivir—Mediastinal disorder—Epirubicin—breast cancer	6.86e-05	0.000279	CcSEcCtD
Oseltamivir—Pain—Docetaxel—breast cancer	6.86e-05	0.000279	CcSEcCtD
Oseltamivir—Back pain—Methotrexate—breast cancer	6.85e-05	0.000279	CcSEcCtD
Oseltamivir—NEU1—Metabolism—STK11—breast cancer	6.84e-05	0.000554	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP19A1—breast cancer	6.84e-05	0.000554	CbGpPWpGaD
Oseltamivir—Dyspepsia—Capecitabine—breast cancer	6.83e-05	0.000278	CcSEcCtD
Oseltamivir—Arrhythmia—Epirubicin—breast cancer	6.8e-05	0.000277	CcSEcCtD
Oseltamivir—Visual impairment—Doxorubicin—breast cancer	6.79e-05	0.000276	CcSEcCtD
Oseltamivir—Asthenia—Paclitaxel—breast cancer	6.79e-05	0.000276	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—VEGFA—breast cancer	6.72e-05	0.000545	CbGpPWpGaD
Oseltamivir—Nausea—Gemcitabine—breast cancer	6.71e-05	0.000273	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—HGF—breast cancer	6.71e-05	0.000544	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PLA2G4A—breast cancer	6.71e-05	0.000544	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Capecitabine—breast cancer	6.7e-05	0.000273	CcSEcCtD
Oseltamivir—Fatigue—Capecitabine—breast cancer	6.69e-05	0.000272	CcSEcCtD
Oseltamivir—Mental disorder—Epirubicin—breast cancer	6.67e-05	0.000271	CcSEcCtD
Oseltamivir—Erythema multiforme—Doxorubicin—breast cancer	6.66e-05	0.000271	CcSEcCtD
Oseltamivir—Pain—Capecitabine—breast cancer	6.64e-05	0.00027	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—CSF2—breast cancer	6.63e-05	0.000538	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Docetaxel—breast cancer	6.61e-05	0.000269	CcSEcCtD
Oseltamivir—Nausea—Fluorouracil—breast cancer	6.6e-05	0.000269	CcSEcCtD
Oseltamivir—Eye disorder—Doxorubicin—breast cancer	6.58e-05	0.000268	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Docetaxel—breast cancer	6.56e-05	0.000267	CcSEcCtD
Oseltamivir—NEU2—Metabolism—CYP17A1—breast cancer	6.55e-05	0.000531	CbGpPWpGaD
Oseltamivir—Anaemia—Methotrexate—breast cancer	6.54e-05	0.000266	CcSEcCtD
Oseltamivir—Cardiac disorder—Doxorubicin—breast cancer	6.54e-05	0.000266	CcSEcCtD
Oseltamivir—NEU2—Metabolism—ENO1—breast cancer	6.48e-05	0.000525	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTGS1—breast cancer	6.48e-05	0.000525	CbGpPWpGaD
Oseltamivir—Diarrhoea—Paclitaxel—breast cancer	6.47e-05	0.000263	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—CFL1—breast cancer	6.46e-05	0.000524	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.46e-05	0.000524	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.42e-05	0.00052	CbGpPWpGaD
Oseltamivir—Back pain—Epirubicin—breast cancer	6.41e-05	0.000261	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—GRB7—breast cancer	6.4e-05	0.000519	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—breast cancer	6.4e-05	0.000519	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Capecitabine—breast cancer	6.4e-05	0.00026	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.37e-05	0.000517	CbGpPWpGaD
Oseltamivir—Immune system disorder—Doxorubicin—breast cancer	6.36e-05	0.000259	CcSEcCtD
Oseltamivir—Vertigo—Methotrexate—breast cancer	6.36e-05	0.000259	CcSEcCtD
Oseltamivir—NEU1—Metabolism—COMT—breast cancer	6.36e-05	0.000515	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP2D6—breast cancer	6.36e-05	0.000515	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Capecitabine—breast cancer	6.35e-05	0.000258	CcSEcCtD
Oseltamivir—Mediastinal disorder—Doxorubicin—breast cancer	6.35e-05	0.000258	CcSEcCtD
Oseltamivir—Body temperature increased—Docetaxel—breast cancer	6.34e-05	0.000258	CcSEcCtD
Oseltamivir—Abdominal pain—Docetaxel—breast cancer	6.34e-05	0.000258	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GSTP1—breast cancer	6.33e-05	0.000513	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—TUBB3—breast cancer	6.32e-05	0.000513	CbGpPWpGaD
Oseltamivir—Arrhythmia—Doxorubicin—breast cancer	6.29e-05	0.000256	CcSEcCtD
Oseltamivir—Dizziness—Paclitaxel—breast cancer	6.26e-05	0.000255	CcSEcCtD
Oseltamivir—NEU1—Metabolism—HMOX1—breast cancer	6.24e-05	0.000506	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NCOA2—breast cancer	6.24e-05	0.000506	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ITPR1—breast cancer	6.22e-05	0.000505	CbGpPWpGaD
Oseltamivir—Cough—Methotrexate—breast cancer	6.18e-05	0.000251	CcSEcCtD
Oseltamivir—Mental disorder—Doxorubicin—breast cancer	6.17e-05	0.000251	CcSEcCtD
Oseltamivir—Urticaria—Capecitabine—breast cancer	6.17e-05	0.000251	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—CXCL8—breast cancer	6.17e-05	0.0005	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—TGFB1—breast cancer	6.16e-05	0.0005	CbGpPWpGaD
Oseltamivir—Body temperature increased—Capecitabine—breast cancer	6.14e-05	0.00025	CcSEcCtD
Oseltamivir—Abdominal pain—Capecitabine—breast cancer	6.14e-05	0.00025	CcSEcCtD
Oseltamivir—Convulsion—Methotrexate—breast cancer	6.14e-05	0.00025	CcSEcCtD
Oseltamivir—Anaemia—Epirubicin—breast cancer	6.12e-05	0.000249	CcSEcCtD
Oseltamivir—Agitation—Epirubicin—breast cancer	6.09e-05	0.000248	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—TUBB3—breast cancer	6.06e-05	0.000491	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—FASN—breast cancer	6.05e-05	0.000491	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ALDOA—breast cancer	6.04e-05	0.00049	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—VEGFC—breast cancer	6.04e-05	0.00049	CbGpPWpGaD
Oseltamivir—Arthralgia—Methotrexate—breast cancer	6.03e-05	0.000245	CcSEcCtD
Oseltamivir—Myalgia—Methotrexate—breast cancer	6.03e-05	0.000245	CcSEcCtD
Oseltamivir—NEU2—Metabolism—BCHE—breast cancer	6.03e-05	0.000488	CbGpPWpGaD
Oseltamivir—Vomiting—Paclitaxel—breast cancer	6.01e-05	0.000245	CcSEcCtD
Oseltamivir—NEU1—Metabolism—ABCB1—breast cancer	5.99e-05	0.000485	CbGpPWpGaD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.99e-05	0.000244	CcSEcCtD
Oseltamivir—Rash—Paclitaxel—breast cancer	5.96e-05	0.000243	CcSEcCtD
Oseltamivir—Dermatitis—Paclitaxel—breast cancer	5.96e-05	0.000243	CcSEcCtD
Oseltamivir—Vertigo—Epirubicin—breast cancer	5.95e-05	0.000242	CcSEcCtD
Oseltamivir—NEU2—Metabolism—SLC5A5—breast cancer	5.95e-05	0.000483	CbGpPWpGaD
Oseltamivir—Back pain—Doxorubicin—breast cancer	5.93e-05	0.000241	CcSEcCtD
Oseltamivir—Headache—Paclitaxel—breast cancer	5.93e-05	0.000241	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	5.91e-05	0.00048	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Docetaxel—breast cancer	5.91e-05	0.00024	CcSEcCtD
Oseltamivir—NEU1—Metabolism—TYMS—breast cancer	5.88e-05	0.000477	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—breast cancer	5.87e-05	0.000476	CbGpPWpGaD
Oseltamivir—Confusional state—Methotrexate—breast cancer	5.83e-05	0.000237	CcSEcCtD
Oseltamivir—NEU1—Metabolism—PLA2G4A—breast cancer	5.81e-05	0.000471	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTM1—breast cancer	5.81e-05	0.000471	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—NCOR1—breast cancer	5.81e-05	0.000471	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—IGF1—breast cancer	5.81e-05	0.000471	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ABCG2—breast cancer	5.79e-05	0.00047	CbGpPWpGaD
Oseltamivir—Cough—Epirubicin—breast cancer	5.78e-05	0.000235	CcSEcCtD
Oseltamivir—Anaphylactic shock—Methotrexate—breast cancer	5.78e-05	0.000235	CcSEcCtD
Oseltamivir—Asthenia—Docetaxel—breast cancer	5.75e-05	0.000234	CcSEcCtD
Oseltamivir—NEU2—Metabolism—SLC2A1—breast cancer	5.75e-05	0.000466	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NQO1—breast cancer	5.75e-05	0.000466	CbGpPWpGaD
Oseltamivir—Convulsion—Epirubicin—breast cancer	5.74e-05	0.000234	CcSEcCtD
Oseltamivir—Infection—Methotrexate—breast cancer	5.74e-05	0.000234	CcSEcCtD
Oseltamivir—Hypersensitivity—Capecitabine—breast cancer	5.72e-05	0.000233	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—CTNNB1—breast cancer	5.69e-05	0.000461	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Methotrexate—breast cancer	5.67e-05	0.000231	CcSEcCtD
Oseltamivir—Anaemia—Doxorubicin—breast cancer	5.67e-05	0.000231	CcSEcCtD
Oseltamivir—Thrombocytopenia—Methotrexate—breast cancer	5.66e-05	0.00023	CcSEcCtD
Oseltamivir—Arthralgia—Epirubicin—breast cancer	5.64e-05	0.00023	CcSEcCtD
Oseltamivir—Myalgia—Epirubicin—breast cancer	5.64e-05	0.00023	CcSEcCtD
Oseltamivir—Agitation—Doxorubicin—breast cancer	5.63e-05	0.000229	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.63e-05	0.000456	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—MMP2—breast cancer	5.62e-05	0.000456	CbGpPWpGaD
Oseltamivir—Anxiety—Epirubicin—breast cancer	5.62e-05	0.000229	CcSEcCtD
Oseltamivir—Nausea—Paclitaxel—breast cancer	5.62e-05	0.000229	CcSEcCtD
Oseltamivir—Skin disorder—Methotrexate—breast cancer	5.61e-05	0.000228	CcSEcCtD
Oseltamivir—NEU2—Metabolism—CYP3A4—breast cancer	5.61e-05	0.000454	CbGpPWpGaD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.6e-05	0.000228	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.58e-05	0.000452	CbGpPWpGaD
Oseltamivir—Asthenia—Capecitabine—breast cancer	5.57e-05	0.000227	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GPX1—breast cancer	5.57e-05	0.000451	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP1A1—breast cancer	5.51e-05	0.000447	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP1B1—breast cancer	5.51e-05	0.000447	CbGpPWpGaD
Oseltamivir—Vertigo—Doxorubicin—breast cancer	5.51e-05	0.000224	CcSEcCtD
Oseltamivir—Diarrhoea—Docetaxel—breast cancer	5.49e-05	0.000223	CcSEcCtD
Oseltamivir—NEU1—Metabolism—ERCC2—breast cancer	5.47e-05	0.000443	CbGpPWpGaD
Oseltamivir—Confusional state—Epirubicin—breast cancer	5.45e-05	0.000222	CcSEcCtD
Oseltamivir—Anaphylactic shock—Epirubicin—breast cancer	5.41e-05	0.00022	CcSEcCtD
Oseltamivir—NEU2—Metabolism—HSP90AA1—breast cancer	5.4e-05	0.000438	CbGpPWpGaD
Oseltamivir—Infection—Epirubicin—breast cancer	5.37e-05	0.000219	CcSEcCtD
Oseltamivir—Cough—Doxorubicin—breast cancer	5.35e-05	0.000218	CcSEcCtD
Oseltamivir—Convulsion—Doxorubicin—breast cancer	5.31e-05	0.000216	CcSEcCtD
Oseltamivir—Diarrhoea—Capecitabine—breast cancer	5.31e-05	0.000216	CcSEcCtD
Oseltamivir—Nervous system disorder—Epirubicin—breast cancer	5.3e-05	0.000216	CcSEcCtD
Oseltamivir—Dizziness—Docetaxel—breast cancer	5.3e-05	0.000216	CcSEcCtD
Oseltamivir—Thrombocytopenia—Epirubicin—breast cancer	5.3e-05	0.000215	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Methotrexate—breast cancer	5.27e-05	0.000214	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC2A2—breast cancer	5.26e-05	0.000426	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NCOA1—breast cancer	5.26e-05	0.000426	CbGpPWpGaD
Oseltamivir—Skin disorder—Epirubicin—breast cancer	5.25e-05	0.000214	CcSEcCtD
Oseltamivir—Insomnia—Methotrexate—breast cancer	5.23e-05	0.000213	CcSEcCtD
Oseltamivir—Myalgia—Doxorubicin—breast cancer	5.22e-05	0.000212	CcSEcCtD
Oseltamivir—Arthralgia—Doxorubicin—breast cancer	5.22e-05	0.000212	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—FN1—breast cancer	5.21e-05	0.000422	CbGpPWpGaD
Oseltamivir—Anxiety—Doxorubicin—breast cancer	5.2e-05	0.000212	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.18e-05	0.000211	CcSEcCtD
Oseltamivir—NEU2—Metabolism—CYP19A1—breast cancer	5.18e-05	0.00042	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—STK11—breast cancer	5.18e-05	0.00042	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—TFRC—breast cancer	5.16e-05	0.000419	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ABCG2—breast cancer	5.15e-05	0.000418	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—MTHFR—breast cancer	5.14e-05	0.000417	CbGpPWpGaD
Oseltamivir—Dizziness—Capecitabine—breast cancer	5.13e-05	0.000209	CcSEcCtD
Oseltamivir—Vomiting—Docetaxel—breast cancer	5.1e-05	0.000207	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—TGFB2—breast cancer	5.09e-05	0.000412	CbGpPWpGaD
Oseltamivir—Dyspepsia—Methotrexate—breast cancer	5.09e-05	0.000207	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—THBS1—breast cancer	5.06e-05	0.00041	CbGpPWpGaD
Oseltamivir—Rash—Docetaxel—breast cancer	5.06e-05	0.000206	CcSEcCtD
Oseltamivir—Dermatitis—Docetaxel—breast cancer	5.05e-05	0.000206	CcSEcCtD
Oseltamivir—Confusional state—Doxorubicin—breast cancer	5.05e-05	0.000205	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC2A2—breast cancer	5.04e-05	0.000409	CbGpPWpGaD
Oseltamivir—Headache—Docetaxel—breast cancer	5.02e-05	0.000204	CcSEcCtD
Oseltamivir—Anaphylactic shock—Doxorubicin—breast cancer	5e-05	0.000204	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Methotrexate—breast cancer	4.99e-05	0.000203	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—GATA3—breast cancer	4.99e-05	0.000404	CbGpPWpGaD
Oseltamivir—Fatigue—Methotrexate—breast cancer	4.98e-05	0.000203	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—breast cancer	4.98e-05	0.000404	CbGpPWpGaD
Oseltamivir—Infection—Doxorubicin—breast cancer	4.97e-05	0.000202	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—NCOA2—breast cancer	4.97e-05	0.000403	CbGpPWpGaD
Oseltamivir—Pain—Methotrexate—breast cancer	4.94e-05	0.000201	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ABCG2—breast cancer	4.94e-05	0.000401	CbGpPWpGaD
Oseltamivir—Vomiting—Capecitabine—breast cancer	4.94e-05	0.000201	CcSEcCtD
Oseltamivir—ABCC4—Ectoderm Differentiation—CTNNB1—breast cancer	4.93e-05	0.0004	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Epirubicin—breast cancer	4.93e-05	0.000201	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—EGF—breast cancer	4.92e-05	0.000399	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Doxorubicin—breast cancer	4.91e-05	0.0002	CcSEcCtD
Oseltamivir—Thrombocytopenia—Doxorubicin—breast cancer	4.9e-05	0.000199	CcSEcCtD
Oseltamivir—Rash—Capecitabine—breast cancer	4.89e-05	0.000199	CcSEcCtD
Oseltamivir—Insomnia—Epirubicin—breast cancer	4.89e-05	0.000199	CcSEcCtD
Oseltamivir—Dermatitis—Capecitabine—breast cancer	4.89e-05	0.000199	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.86e-05	0.000394	CbGpPWpGaD
Oseltamivir—Headache—Capecitabine—breast cancer	4.86e-05	0.000198	CcSEcCtD
Oseltamivir—Skin disorder—Doxorubicin—breast cancer	4.86e-05	0.000198	CcSEcCtD
Oseltamivir—NEU2—Metabolism—COMT—breast cancer	4.82e-05	0.000391	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTP1—breast cancer	4.79e-05	0.000389	CbGpPWpGaD
Oseltamivir—Nausea—Docetaxel—breast cancer	4.76e-05	0.000194	CcSEcCtD
Oseltamivir—Feeling abnormal—Methotrexate—breast cancer	4.76e-05	0.000194	CcSEcCtD
Oseltamivir—Dyspepsia—Epirubicin—breast cancer	4.76e-05	0.000194	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	4.74e-05	0.000385	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CAV1—breast cancer	4.74e-05	0.000384	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—HMOX1—breast cancer	4.73e-05	0.000383	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Methotrexate—breast cancer	4.73e-05	0.000192	CcSEcCtD
Oseltamivir—NEU2—Metabolism—ITPR1—breast cancer	4.72e-05	0.000382	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—CXCL8—breast cancer	4.67e-05	0.000379	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Epirubicin—breast cancer	4.67e-05	0.00019	CcSEcCtD
Oseltamivir—Fatigue—Epirubicin—breast cancer	4.66e-05	0.00019	CcSEcCtD
Oseltamivir—Pain—Epirubicin—breast cancer	4.62e-05	0.000188	CcSEcCtD
Oseltamivir—Nausea—Capecitabine—breast cancer	4.61e-05	0.000188	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—TFRC—breast cancer	4.59e-05	0.000372	CbGpPWpGaD
Oseltamivir—Urticaria—Methotrexate—breast cancer	4.59e-05	0.000187	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	4.58e-05	0.000371	CbGpPWpGaD
Oseltamivir—Abdominal pain—Methotrexate—breast cancer	4.57e-05	0.000186	CcSEcCtD
Oseltamivir—Body temperature increased—Methotrexate—breast cancer	4.57e-05	0.000186	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—IGF1—breast cancer	4.56e-05	0.00037	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.56e-05	0.000186	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—AKT2—breast cancer	4.56e-05	0.00037	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ABCB1—breast cancer	4.54e-05	0.000368	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.53e-05	0.000367	CbGpPWpGaD
Oseltamivir—Insomnia—Doxorubicin—breast cancer	4.53e-05	0.000184	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—IFNB1—breast cancer	4.48e-05	0.000363	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—TYMS—breast cancer	4.46e-05	0.000361	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Epirubicin—breast cancer	4.46e-05	0.000181	CcSEcCtD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—ALB—breast cancer	4.45e-05	0.000361	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Epirubicin—breast cancer	4.42e-05	0.00018	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—NCOA2—breast cancer	4.42e-05	0.000358	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NCOR1—breast cancer	4.41e-05	0.000357	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PLA2G4A—breast cancer	4.41e-05	0.000357	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTM1—breast cancer	4.41e-05	0.000357	CbGpPWpGaD
Oseltamivir—Dyspepsia—Doxorubicin—breast cancer	4.41e-05	0.000179	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—TFRC—breast cancer	4.4e-05	0.000357	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—breast cancer	4.38e-05	0.000355	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—breast cancer	4.33e-05	0.000351	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—ALB—breast cancer	4.32e-05	0.00035	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Doxorubicin—breast cancer	4.32e-05	0.000176	CcSEcCtD
Oseltamivir—NEU1—Metabolism—PIK3CG—breast cancer	4.32e-05	0.00035	CbGpPWpGaD
Oseltamivir—Fatigue—Doxorubicin—breast cancer	4.31e-05	0.000176	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—CTNNB1—breast cancer	4.31e-05	0.00035	CbGpPWpGaD
Oseltamivir—Urticaria—Epirubicin—breast cancer	4.3e-05	0.000175	CcSEcCtD
Oseltamivir—Pain—Doxorubicin—breast cancer	4.28e-05	0.000174	CcSEcCtD
Oseltamivir—Abdominal pain—Epirubicin—breast cancer	4.28e-05	0.000174	CcSEcCtD
Oseltamivir—Body temperature increased—Epirubicin—breast cancer	4.28e-05	0.000174	CcSEcCtD
Oseltamivir—Hypersensitivity—Methotrexate—breast cancer	4.26e-05	0.000173	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—NCOA2—breast cancer	4.24e-05	0.000344	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GPX1—breast cancer	4.22e-05	0.000342	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC5A5—breast cancer	4.22e-05	0.000342	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—NCOA1—breast cancer	4.19e-05	0.00034	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP1A1—breast cancer	4.18e-05	0.000339	CbGpPWpGaD
Oseltamivir—Asthenia—Methotrexate—breast cancer	4.15e-05	0.000169	CcSEcCtD
Oseltamivir—NEU2—Metabolism—ERCC2—breast cancer	4.14e-05	0.000336	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Doxorubicin—breast cancer	4.12e-05	0.000168	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—PLAUR—breast cancer	4.11e-05	0.000334	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Doxorubicin—breast cancer	4.09e-05	0.000167	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—PLG—breast cancer	4.08e-05	0.000331	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC2A1—breast cancer	4.07e-05	0.00033	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC5A5—breast cancer	4.04e-05	0.000328	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PLG—breast cancer	4.02e-05	0.000326	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—MYC—breast cancer	4e-05	0.000324	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Epirubicin—breast cancer	3.98e-05	0.000162	CcSEcCtD
Oseltamivir—Urticaria—Doxorubicin—breast cancer	3.98e-05	0.000162	CcSEcCtD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—ALB—breast cancer	3.96e-05	0.000321	CbGpPWpGaD
Oseltamivir—Body temperature increased—Doxorubicin—breast cancer	3.96e-05	0.000161	CcSEcCtD
Oseltamivir—Abdominal pain—Doxorubicin—breast cancer	3.96e-05	0.000161	CcSEcCtD
Oseltamivir—Diarrhoea—Methotrexate—breast cancer	3.95e-05	0.000161	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—RAF1—breast cancer	3.91e-05	0.000317	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.91e-05	0.000317	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—MTHFR—breast cancer	3.89e-05	0.000316	CbGpPWpGaD
Oseltamivir—Asthenia—Epirubicin—breast cancer	3.88e-05	0.000158	CcSEcCtD
Oseltamivir—Dizziness—Methotrexate—breast cancer	3.82e-05	0.000156	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—PDGFA—breast cancer	3.82e-05	0.00031	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—breast cancer	3.82e-05	0.000309	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—TGFB1—breast cancer	3.81e-05	0.000309	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CD—breast cancer	3.79e-05	0.000308	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—HMOX1—breast cancer	3.77e-05	0.000305	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ALB—breast cancer	3.75e-05	0.000304	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—NCOA1—breast cancer	3.73e-05	0.000302	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ITPR1—breast cancer	3.7e-05	0.0003	CbGpPWpGaD
Oseltamivir—Diarrhoea—Epirubicin—breast cancer	3.7e-05	0.000151	CcSEcCtD
Oseltamivir—Hypersensitivity—Doxorubicin—breast cancer	3.69e-05	0.00015	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—ABL1—breast cancer	3.68e-05	0.000298	CbGpPWpGaD
Oseltamivir—Vomiting—Methotrexate—breast cancer	3.67e-05	0.00015	CcSEcCtD
Oseltamivir—Rash—Methotrexate—breast cancer	3.64e-05	0.000148	CcSEcCtD
Oseltamivir—Dermatitis—Methotrexate—breast cancer	3.64e-05	0.000148	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—PLG—breast cancer	3.63e-05	0.000294	CbGpPWpGaD
Oseltamivir—Headache—Methotrexate—breast cancer	3.62e-05	0.000147	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ABCB1—breast cancer	3.62e-05	0.000293	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CAV1—breast cancer	3.59e-05	0.000291	CbGpPWpGaD
Oseltamivir—Asthenia—Doxorubicin—breast cancer	3.59e-05	0.000146	CcSEcCtD
Oseltamivir—NEU1—Metabolism—NOS3—breast cancer	3.58e-05	0.00029	CbGpPWpGaD
Oseltamivir—Dizziness—Epirubicin—breast cancer	3.58e-05	0.000146	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—NCOA1—breast cancer	3.57e-05	0.00029	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—IL2—breast cancer	3.51e-05	0.000284	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—PLG—breast cancer	3.48e-05	0.000282	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PLA2G4A—breast cancer	3.46e-05	0.00028	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—HGF—breast cancer	3.46e-05	0.00028	CbGpPWpGaD
Oseltamivir—Vomiting—Epirubicin—breast cancer	3.44e-05	0.00014	CcSEcCtD
Oseltamivir—Nausea—Methotrexate—breast cancer	3.43e-05	0.00014	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.43e-05	0.000278	CbGpPWpGaD
Oseltamivir—Diarrhoea—Doxorubicin—breast cancer	3.42e-05	0.000139	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—CSF2—breast cancer	3.42e-05	0.000277	CbGpPWpGaD
Oseltamivir—Rash—Epirubicin—breast cancer	3.41e-05	0.000139	CcSEcCtD
Oseltamivir—Dermatitis—Epirubicin—breast cancer	3.41e-05	0.000139	CcSEcCtD
Oseltamivir—Headache—Epirubicin—breast cancer	3.39e-05	0.000138	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—HMOX1—breast cancer	3.35e-05	0.000272	CbGpPWpGaD
Oseltamivir—Dizziness—Doxorubicin—breast cancer	3.31e-05	0.000135	CcSEcCtD
Oseltamivir—NEU1—Metabolism—PIK3CB—breast cancer	3.31e-05	0.000268	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTGS2—breast cancer	3.28e-05	0.000266	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CG—breast cancer	3.27e-05	0.000265	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ABCB1—breast cancer	3.22e-05	0.000261	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—HMOX1—breast cancer	3.21e-05	0.00026	CbGpPWpGaD
Oseltamivir—Nausea—Epirubicin—breast cancer	3.21e-05	0.000131	CcSEcCtD
Oseltamivir—Vomiting—Doxorubicin—breast cancer	3.18e-05	0.000129	CcSEcCtD
Oseltamivir—Rash—Doxorubicin—breast cancer	3.16e-05	0.000128	CcSEcCtD
Oseltamivir—Dermatitis—Doxorubicin—breast cancer	3.15e-05	0.000128	CcSEcCtD
Oseltamivir—Headache—Doxorubicin—breast cancer	3.13e-05	0.000128	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ABCB1—breast cancer	3.08e-05	0.00025	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SRC—breast cancer	3.06e-05	0.000248	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—breast cancer	2.98e-05	0.000242	CbGpPWpGaD
Oseltamivir—Nausea—Doxorubicin—breast cancer	2.97e-05	0.000121	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—MMP1—breast cancer	2.94e-05	0.000238	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CDK2—breast cancer	2.89e-05	0.000234	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PLAU—breast cancer	2.89e-05	0.000234	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CD—breast cancer	2.88e-05	0.000233	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTEN—breast cancer	2.86e-05	0.000232	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ALB—breast cancer	2.84e-05	0.00023	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CAV1—breast cancer	2.82e-05	0.000229	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—MAPK3—breast cancer	2.82e-05	0.000228	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—TGFB1—breast cancer	2.73e-05	0.000222	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NOS3—breast cancer	2.72e-05	0.00022	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—FN1—breast cancer	2.68e-05	0.000218	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—NOS2—breast cancer	2.65e-05	0.000215	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CG—breast cancer	2.57e-05	0.000208	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—EGF—breast cancer	2.54e-05	0.000206	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CB—breast cancer	2.51e-05	0.000203	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTGS2—breast cancer	2.48e-05	0.000201	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IGF1—breast cancer	2.35e-05	0.000191	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—AKT2—breast cancer	2.35e-05	0.00019	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	2.33e-05	0.000189	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ALB—breast cancer	2.26e-05	0.000183	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CD—breast cancer	2.26e-05	0.000183	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SERPINE1—breast cancer	2.23e-05	0.000181	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ALB—breast cancer	2.23e-05	0.000181	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTEN—breast cancer	2.17e-05	0.000176	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—NOS3—breast cancer	2.13e-05	0.000173	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—RAF1—breast cancer	2.05e-05	0.000166	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CA—breast cancer	2.02e-05	0.000163	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—RAF1—breast cancer	2.02e-05	0.000163	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ALB—breast cancer	2.01e-05	0.000163	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CB—breast cancer	1.97e-05	0.00016	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ALB—breast cancer	1.93e-05	0.000156	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—AKT1—breast cancer	1.9e-05	0.000154	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—RAF1—breast cancer	1.82e-05	0.000148	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IL2—breast cancer	1.81e-05	0.000146	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—RAF1—breast cancer	1.74e-05	0.000141	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—AKT1—breast cancer	1.65e-05	0.000134	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SRC—breast cancer	1.58e-05	0.000128	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—VEGFA—breast cancer	1.54e-05	0.000125	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CA—breast cancer	1.53e-05	0.000124	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—MAPK3—breast cancer	1.45e-05	0.000118	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TGFB1—breast cancer	1.41e-05	0.000114	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—KRAS—breast cancer	1.31e-05	0.000106	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—AKT1—breast cancer	1.25e-05	0.000101	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CA—breast cancer	1.2e-05	9.72e-05	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TP53—breast cancer	1.16e-05	9.41e-05	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—HRAS—breast cancer	1.11e-05	9e-05	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—AKT1—breast cancer	9.8e-06	7.94e-05	CbGpPWpGaD
